NIR light can treat brain diseases. Transcranial light therapy shines NIR wavelengths onto the forehead. Transnasal light therapy involves shining light through the nose into the central area of the brain.
Light therapy helps damaged neurons replenish and repair by stimulating mitochondria, reducing inflammation and increasing circulation.
Numerous studies, including this one, have shown that transcranial red light therapy can improve cognitive function in people with dementia, help heal traumatic brain injuries (TBI) and strokes, alleviate mental and mood disorders such as anxiety and depression, and slow down or Reverse age-related cognitive decline and relieve symptoms of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.
Age-Related Cognitive Decline Neurodegenerative Diseases NIR light therapy has high potential value in treating dementia, Alzheimer's disease (AD), and Parkinson's disease (PD)
Dementia, including Alzheimer's disease (AD), affects approximately 7 million U.S. adults, and this number is expected to rise as the baby boom generation ages.
Patients with mild to moderate dementia received 12 weeks of therapy consisting of weekly transcranial/transnasal therapy in the clinic and daily intranasal phototherapy at home. The second phase was a 4-week therapy-free period.
After 12 weeks, there were significant improvements in memory recall, visual attention, task switching, executive brain function, and other measures of cognitive performance. After therapy, the patient also slept better, had fewer outbursts of anger and anxiety, and had less mind wandering. Because patients' sleep quality significantly decreased during the untreated period, the authors believe that continued therapy is critical to controlling dementia and AD.
Parkinson's disease is characterized by the slow degeneration of neurons related to motor and non-motor functions. A study of age-related cognitive decline also noted reduced tremors and improved balance in patients with Parkinson's disease-related dementia.
Parkinson's disease is caused by the death of neurons in the midbrain. The authors suggest that near-infrared light therapy can stabilize dying neurons, potentially slowing the progression of the disease.